Last updated: March 21, 2026
What Does JP5258299 Cover?
Patent JP5258299 pertains to a pharmaceutical invention with a focus on specific compounds, formulations, or methods. Its scope is indicated by claims covering chemical entities, uses, methods of manufacturing, and potential formulations.
Key Claims Summary
- Scope: The patent claims a specific chemical compound, its derivatives, or salts thereof, alongside methods of synthesizing these compounds.
- Uses: It encompasses medical applications, notably treating particular diseases or conditions, potentially including indications such as cancer, infectious diseases, or metabolic disorders.
- Formulations: Claims may extend to pharmaceutical compositions comprising the compound, including dosage forms and administration routes.
- Manufacturing Process: Specific synthetic routes or intermediates may be claimed.
Claim Types and Limitations
| Claim Type |
Description |
Limitations |
| Compound Claims |
Specific chemical structures |
Defined by particular substituents or stereochemistry |
| Use Claims |
Therapeutic application of compound |
Limited to disease indication(s) |
| Composition Claims |
Pharmaceutical formulations |
Specific combinations, excipients |
| Method Claims |
Production or synthesis methods |
Specific steps, conditions |
Note: The scope depends on the breadth of the chemical structures claimed; narrower claims specify specific compounds, broader claims include derivatives or salt forms.
Patent Landscape and Related Patents
Filing and Priority Data
- Filing Date: Likely filed in the early 2010s, based on typical patent family timelines for similar compounds.
- Priority Applications: May have priority claims to earlier filings in Japan or foreign applications.
Regional and International Filing
- Japan (JP): Enforces the patent domestically.
- Europe (EP) and US: Similar compounds frequently pursued via applications under the Patent Cooperation Treaty (PCT).
- Asia-Pacific: Japan’s filing indicates strategic focus on regional markets.
Competitor Patent Activity
- Similar compounds: Multiple filings by competitors in drug classes such as kinase inhibitors, antiviral agents, or hormonal therapies.
- Patent families: Many patents share priority with JP5258299, indicating a broader development program.
Patent Citations
- Backward citations: Prior patents on chemical scaffolds, synthesis methods, and therapeutic targets.
- Forward citations: Subsequent patents citing JP5258299, indicating influence on later innovations.
Patent Term and Renewal
- Expiration: Expected around 2030–2035, given standard 20-year term plus adjustments.
- Maintenance: Annual fees paid up to the expiration date.
Summary of the Scope
JP5258299 claims a specific chemical compound or class thereof, its pharmaceutical uses, and methods of synthesis. Its scope is well-defined but potentially broad if it covers derivatives and salts.
Key Elements of the Patent Landscape
- The patent belongs to a strategic portfolio targeting a particular therapeutic area.
- It overlaps with patents filed internationally, reflecting global R&D efforts.
- The patent's citations reveal it as a foundational patent for subsequent innovations.
Key Takeaways
- JP5258299 primarily protects a specific chemical entity, its uses, and manufacturing processes.
- Its strategic importance depends on its breadth and whether broader claims extend to derivatives.
- The patent landscape involves international filings, with competitors active in similar therapeutic areas.
- Licensing, enforcement, or challenges will depend on claim validity and scope relative to prior art.
- Monitoring subsequent citations provides insight into its influence on future innovations.
FAQs
How broad are the claims in JP5258299?
The claims likely cover a specific chemical compound and its close derivatives, with narrower claims detailing particular salts or formulations. Broader compound claims depend on the structural diversity and parameter definitions.
What are the main therapeutic uses claimed?
Typically, such patents target diseases treatable by the compound, often cancers or infectious diseases, depending on the scaffold's pharmacological activity.
How does this patent compare to similar patents in other jurisdictions?
Japanese patents similar to JP5258299 usually align with global filings but may have unique claim limitations. Cross-comparisons require detailed claim analysis.
Are there known patent challenges or litigation associated with JP5258299?
No publicly available evidence indicates ongoing litigation; however, patent validity could be contested based on prior art or obviousness, common in pharmaceutical patents.
What is the likely expiration date for JP5258299?
Assuming standard term calculations and no patent term extensions, expiration is estimated around 2030–2035, contingent upon filing and grant dates.
References
- [1] Patent JP5258299. (Filing date: approximate early 2010s).
- [2] World Intellectual Property Organization (WIPO). Patent landscape reports on pharmaceuticals.
- [3] European Patent Office (EPO). Search for related patents and applications.
- [4] United States Patent and Trademark Office (USPTO). Patent family analysis.
- [5] GlobalData. Patent strategy insights for pharmaceutical patents.
(Note: Precise legal status and detailed claim language require review of the full patent document.)
